Companies / Creative Biolabs / Anti-PDCD1 Recombinant Antibody (Nivolumab)
Creative Biolabs

Anti-PDCD1 Recombinant Antibody (Nivolumab) | Creative Biolabs

Recombinant human monoclonal antibody expressed in CHO binding to human PDCD1. Nivolumab is a fully human IgG4 monoclonal antibody for the treatment of cancer. Nivolumab acts as an immunomodulator by blocking ligand activation of the programmed cell death 1 (PD-1) receptor on activated T cells.

Supporting Documents


Data Sheet

Datasheet

MSDS

MSDS

Reviews


No reviews yet